Showing results (681-690 of 730) with videos related to
Sort By:
Pageof 73
Neuro-Oncology Advances|July 10, 2020
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastasesAnna Sophie Berghoff, Michael Oliver Breckwoldt, Lars Riedemann, et al.Cell Reports|July 25, 2019
Single-Cell Analysis Suggests that Ongoing Affinity Maturation Drives the Emergence of Pemphigus Vulgaris Autoimmune DiseaseAlice Cho, Amber L Caldara, Nina A Ran, et al.Oncotarget|September 18, 2015
Human mesenchymal stem cells enhance the systemic effects of radiotherapyVirgínea de Araújo Farias, Francisco O'Valle, Borja Alonso Lerma, et al.Nature|December 20, 2013
The genome of the recently domesticated crop plant sugar beet (Beta vulgaris)Juliane C Dohm, André E Minoche, Daniela Holtgräwe, et al.BMC Cardiovascular Disorders|July 5, 2018
Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trialSusanne S Pedersen, Søren J Skovbakke, Uffe K Wiil, et al.Surgical Endoscopy|May 9, 2025
Vascularity of the gastric conduit predicts complications after Ivor-Lewis esophagectomyJulian Lemties, Carolin Scheidt, Jin-On Jung, et al.JACC. Heart Failure|August 15, 2021
Prognostic Value of Peak Oxygen Uptake in Patients Supported With Left Ventricular Assist Devices (PRO-VAD)Kiran K Mirza, Mariusz K Szymanski, Thomas Schmidt, et al.Oncoimmunology|April 11, 2018
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancerFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, et al.Scientific Reports|April 22, 2022
Next generation automated traceless cell chromatography platform for GMP-compliant cell isolation and activationSabine Radisch, Mateusz P Poltorak, Michaela Wagner, et al.Journal of Experimental & Clinical Cancer Research : CR|January 2, 2024
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cellsCecilia Bergonzini, Alessandro Gregori, Tessa M S Hagens, et al.Pageof 73